About us Career Contact us
Location:Home>Drug Discovery Pipeline>Core Technologies

Core Technology Groups

Medicinal Chemistry
Team Leader: Dr. Ke Ding

Medicinal chemistry research group specializes in the discovery and development of novel small molecule chemical entities with intellectual rights (IPRs). The research priorities of this group are to discover the drugs for the treatment of major diseases, such as cancer, Alzheimer’s disease, diabetes, infectious diseases, and inflammation...

High Throughput Drug Screening
Group Leader: Tu Zhengchao

Screening the potency of a compound is a common starting point for new drug discovery. High-throughput screening (HTS) allows the testing of many compounds in a short time and is an important area of drug discover research. Unfortunately, China started investing in HTS technology very late...

Structural Biology
Group Leader: Liu Jinsong

Dr. Jinsong Liu is a structural biologist who has worked for over 10 years with biotechnology companies, research institution from the USA and China. He is an author of over 20 peer-reviewed journal articles and patents....

BioTherapeutics
Group Leader: Dr. Daiguan Yu

Biological macromolecular drugs are therapeutic antibodies, therapeutic proteins, and therapeutic vaccines. Macromolecular drug development usually needs significant investment in research and development (R & D), e.g. drug target identification, recombinant protein production, and humanized antibody development...

Chemical Analysis
Group Leader: Zhang Yanmei

Dr. Zhang, received her B.S. in chemistry from Shandong University in 1995. She studied organofluorine chemistry in Shanghai Institute of Organic Chemistry, CAS as a Master student. In 1998, she joined National Center for Drug Screening and worked on the setup of compound library by combinatorial chemistry and natural product purification......

Drug Metabolism and Pharmacokinetics 
Lab Leader:Liu Xiaorong


The goal of the Drug Metabolism and Pharmacokinetics’ Group is to establish an internationally first-class pre-clinical drug research and drug safety evaluation laboratory. Our studies mainly focus on drug metabolism , pharmacokinetics, drug safety ..

Genome Regulation Laboratory

Group Leader:RALF JAUCH


Ralf studied Biology, Psychology and Archeology in Jena (Germany) and Manchester (UK) before doing his PhD in a molecular biology program from 2001-2005 at the Max-Planck-Institut für biophyskalische Chemie in G?ttingen, Germany. In 2006 he got attracted to Singapore to join the recently established Genome Institute of Singapore......

Back

Copyright ©2002-2008 Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences